Showing results (601-610 of 5,680) with videos related to

Sort By:
Pageof 568
The Oncologist|May 10, 2000
Prognostic value of vascular endothelial growth factor in breast cancerG Gasparini
The Oncologist|July 15, 2000
The impact of fatigue on patients with cancer: overview of FATIGUE 1 and 2G A Curt
The Oncologist|October 5, 2001
Answering patients' needs: oral alternatives to intravenous therapyM Borner, W Scheithauer, C Twelves, et al.
The Oncologist|October 5, 2001
Optimizing the use of irinotecan in colorectal cancerD Cunningham, J Maroun, U Vanhoefer, et al.
The Oncologist|October 5, 2001
Improving chemoradiotherapy in rectal cancerR Glynne-Jones, J Debus
The Oncologist|May 2, 2001
Introduction: the history of arsenic trioxide in cancer therapyK H Antman
The Oncologist|May 2, 2001
History of the development of arsenic derivatives in cancer therapyS Waxman, K C Anderson
The Oncologist|May 11, 2001
Docetaxel and epirubicin in advanced breast cancerC Sessa, O Pagani
The Oncologist|October 21, 2000
Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue CoalitionG A Curt, W Breitbart, D Cella, et al.
The Oncologist|February 22, 2001
Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: a preliminary report of a phase I dose escalation trial from the Carolina Conformal Therapy ConsortiumM A Socinski, L B Marks, J Garst, et al.
Pageof 568